E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors

Radzey H, Rethmeier M, Klimpel D, Grundhuber M, Sommerhoff CP, Schaschke N (2013)
Chemmedchem 8(8): 1314-1321.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Radzey, Hanna; Rethmeier, Markus; Klimpel, DennisUniBi; Grundhuber, Maresa; Sommerhoff, Christian P.; Schaschke, NorbertUniBi
Abstract / Bemerkung
Cathepsin C is a papain-like cysteine protease with dipeptidyl aminopeptidase activity that is thought to activate various granule-associated serine proteases. Its exopeptidase activity is structurally explained by the so-called exclusion domain, which blocks the active-site cleft beyond the S2 site and, with its Asp1 residue, provides an anchoring point for the N terminus of peptide and protein substrates. Here, the hydrazide of (2S,3S)-trans-epoxysuccinyl-l-leucylamido-3-methylbutane (E-64c) (k(2)/K-i=140 +/- 5 M-1 s(-1)) is demonstrated to be a lead structure for the development of irreversible cathepsin C inhibitors. The distal amino group of the hydrazide moiety addresses the acidic Asp1 residue at the entrance of the S2 pocket by hydrogen bonding while also occupying the flat hydrophobic S1'-S2' area with its leucine-isoamylamide moiety. Furthermore, structure-activity relationship studies revealed that functionalization of this distal amino group with alkyl residues can be used to occupy the conserved hydrophobic S2 pocket. In particular, the n-butyl derivative was identified as the most potent inhibitor of the series (k(2)/K-i=56000 +/- 1700 M-1 s(-1)).
Stichworte
cathepsinC; papain-like; cysteine proteases; structure-activity relationships; hydrazines; dipeptidyl peptidaseI (DPPI); E-64
Erscheinungsjahr
2013
Zeitschriftentitel
Chemmedchem
Band
8
Ausgabe
8
Seite(n)
1314-1321
ISSN
1860-7179
Page URI
https://pub.uni-bielefeld.de/record/2622177

Zitieren

Radzey H, Rethmeier M, Klimpel D, Grundhuber M, Sommerhoff CP, Schaschke N. E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors. Chemmedchem. 2013;8(8):1314-1321.
Radzey, H., Rethmeier, M., Klimpel, D., Grundhuber, M., Sommerhoff, C. P., & Schaschke, N. (2013). E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors. Chemmedchem, 8(8), 1314-1321. doi:10.1002/cmdc.201300093
Radzey, Hanna, Rethmeier, Markus, Klimpel, Dennis, Grundhuber, Maresa, Sommerhoff, Christian P., and Schaschke, Norbert. 2013. “E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors”. Chemmedchem 8 (8): 1314-1321.
Radzey, H., Rethmeier, M., Klimpel, D., Grundhuber, M., Sommerhoff, C. P., and Schaschke, N. (2013). E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors. Chemmedchem 8, 1314-1321.
Radzey, H., et al., 2013. E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors. Chemmedchem, 8(8), p 1314-1321.
H. Radzey, et al., “E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors”, Chemmedchem, vol. 8, 2013, pp. 1314-1321.
Radzey, H., Rethmeier, M., Klimpel, D., Grundhuber, M., Sommerhoff, C.P., Schaschke, N.: E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors. Chemmedchem. 8, 1314-1321 (2013).
Radzey, Hanna, Rethmeier, Markus, Klimpel, Dennis, Grundhuber, Maresa, Sommerhoff, Christian P., and Schaschke, Norbert. “E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors”. Chemmedchem 8.8 (2013): 1314-1321.

2 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.
Mirea AM, Tack CJ, Chavakis T, Joosten LAB, Toonen EJM., Trends Mol Med 24(5), 2018
PMID: 29665983
Development of the first internally-quenched fluorescent substrates of human cathepsin C: The application in the enzyme detection in biological samples.
Łęgowska M, Hamon Y, Wojtysiak A, Grzywa R, Sieńczyk M, Burster T, Korkmaz B, Lesner A., Arch Biochem Biophys 612(), 2016
PMID: 27746119

35 References

Daten bereitgestellt von Europe PubMed Central.


AUTHOR UNKNOWN, 0

Turk, 2004
Inactivation and degradation of glucagon by dipeptidyl aminopeptidase I (cathepsin C) of rat liver.
McDonald JK, Callahan PX, Zeitman BB, Ellis S., J. Biol. Chem. 244(22), 1969
PMID: 5389103
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases.
Turk D, Janjic V, Stern I, Podobnik M, Lamba D, Dahl SW, Lauritzen C, Pedersen J, Turk V, Turk B., EMBO J. 20(23), 2001
PMID: 11726493
The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.
Molgaard A, Arnau J, Lauritzen C, Larsen S, Petersen G, Pedersen J., Biochem. J. 401(3), 2007
PMID: 17020538
The primary structure and tissue distribution of cathepsin C.
Kominami E, Ishido K, Muno D, Sato N., Biol. Chem. Hoppe-Seyler 373(7), 1992
PMID: 1515062
Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I.
Pham CT, Armstrong RJ, Zimonjic DB, Popescu NC, Payan DG, Ley TJ., J. Biol. Chem. 272(16), 1997
PMID: 9099719
Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice.
Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH., J. Biol. Chem. 276(21), 2001
PMID: 11279033
Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms.
Pagano MB, Bartoli MA, Ennis TL, Mao D, Simmons PM, Thompson RW, Pham CT., Proc. Natl. Acad. Sci. U.S.A. 104(8), 2007
PMID: 17301245
Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection.
Akk AM, Simmons PM, Chan HW, Agapov E, Holtzman MJ, Grayson MH, Pham CT., J. Immunol. 180(5), 2008
PMID: 18292580
Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, Zlotogorski A, Shapira L, Soskolne WA, Zlorogorski A., J. Med. Genet. 37(2), 2000
PMID: 10662807
Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM, Gotz MG, Koot G, McGuire M, Thiele D, Hudig D, Powers JC., Arch. Biochem. Biophys. 427(2), 2004
PMID: 15196986
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.
Guay D, Beaulieu C, Truchon JF, Jagadeeswar Reddy T, Zamboni R, Bayly CI, Methot N, Rubin J, Ethier D, David Percival M., Bioorg. Med. Chem. Lett. 19(18), 2009
PMID: 19665376
Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI).
Bondebjerg J, Fuglsang H, Valeur KR, Kaznelson DW, Hansen JA, Pedersen RO, Krogh BO, Jensen BS, Lauritzen C, Petersen G, Pedersen J, Naerum L., Bioorg. Med. Chem. 13(14), 2005
PMID: 15893930
Irreversible inhibitors of serine, cysteine, and threonine proteases.
Powers JC, Asgian JL, Ekici OD, James KE., Chem. Rev. 102(12), 2002
PMID: 12475205
Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex.
Yamamoto A, Tomoo K, Matsugi K, Hara T, In Y, Murata M, Kitamura K, Ishida T., Biochim. Biophys. Acta 1597(2), 2002
PMID: 12044902
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K., Biochem. J. 201(1), 1982
PMID: 7044372
E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Turk D, Moroder L., Bioorg. Med. Chem. 5(9), 1997
PMID: 9354234
Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
Busnel O, Bi L, Dali H, Cheguillaume A, Chevance S, Bondon A, Muller S, Baudy-Floc'h M., J. Org. Chem. 70(26), 2005
PMID: 16355988
Novel azapeptide inhibitors of hepatitis C virus serine protease.
Bailey MD, Halmos T, Goudreau N, Lescop E, Llinas-Brunet M., J. Med. Chem. 47(15), 2004
PMID: 15239657

Morrison, Trends Biochem. Sci. 7(), 1982

Knight, 1986
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 23780739
PubMed | Europe PMC

Suchen in

Google Scholar